Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 February 2021 | Story NONSINDISO QWABE | Photo Supplied
Business Management Lecturer, Lebohang Masoabi, who received her MA in Business Management at the February virtual graduation ceremony.

Student-turned-lecturer at the University of Free State (UFS), Lebohang Masoabi, has experienced the best of both worlds. Masoabi, a Business Management Lecturer on the Qwaqwa Campus, received her MA degree with specialisation in Business Management during the ceremony for master’s and doctoral degrees on 24 February 2021. 
She obtained both her BA Corporate Marketing and Communication and BAHons in Business Management degrees from the UFS.

I found my passion and remembered why I started

Masoabi knows a little about delays not being denials, because what was initially supposed to be a two-year qualification took her five years to complete. “It’s been a long journey, and I really have been through a lot to get to this point. Along the way, I lost hope and was ready to give up, but I remembered why I started. Being an academic has always been a dream of mine, and I want to be the best at that, so I remembered that this was my dream, something that I love.”
“Passing on the knowledge that I have learned from this very university is incredible. I think we are one of the most awesome institutions, and I say this with confidence – having been a student myself, and now as an employee of this institution. At one point I was on the receiving end and knowledge was transferred to me, and now I am on the other side transferring that very same knowledge. Now that I am here, I want more. I see myself becoming Professor Lebohang Masoabi one day,” she said.

Entrepreneurship education necessary for students 
Masoabi’s study focused on the role of entrepreneurship education on the attitudes and intentions of university students. She said when she came up with the topic of the study, one of her concerns was that many students studying entrepreneurship did not know what to do with their degrees beyond university, while students in other streams who went on to start businesses after getting their qualifications, lacked the skill and know-how. Her study found that entrepreneurship education had a positive influence on the intentions of students who had entrepreneurship background.

“Entrepreneurship teaches you to cultivate unique skills and to think out of the box. It creates opportunities, which is necessary in a country like ours. If students are given the skills and background of entrepreneurship – with the right opportunities and confidence they get from us as lecturers – they are able to influence their surroundings,” she said.

Master’s degree a message of hope

Masoabi is currently pursuing her PhD in social entrepreneurship, and said her focus was on becoming an expert in the field. “Part of why I started this journey was because of the hope that was given to me as a student at the UFS, the hope that I can be whatever I want to be. This master’s degree is my message of hope to someone looking at my life.”

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept